Clinical trial

A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers

NCT07682948

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-07-01

PhasePHASE1

Study timeline

Study start (estimated)2026-07-01Date precision: day

Registry last updated2026-07-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Dyslipidemiaunresolved

Interventions

Investigational Product 1DRUG

Investigational Product 2DRUG

Investigational Product 1 + Investigational Product 2DRUG

Sponsors & collaborators

Korea United Pharm. Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07682948 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.